Actively Recruiting

Age: 12Years - 20Years
All Genders
NCT05145725

Instrumented POsterolateral Arthrodesis for Adolescent Idiopathic Scoliosis

Led by Elsan · Updated on 2024-02-29

866

Participants Needed

1

Research Sites

782 weeks

Total Duration

On this page

Sponsors

E

Elsan

Lead Sponsor

E

European Clinical Trial Experts Network

Collaborating Sponsor

AI-Summary

What this Trial Is About

The study population concerns adolescent patients with idiopathic scoliosis which requires surgical management and who have a longer waiting period of 6 months. The aim of this study is to research the predictive factors of an improvement in the quality of life of adolescents who have had surgery.

CONDITIONS

Official Title

Instrumented POsterolateral Arthrodesis for Adolescent Idiopathic Scoliosis

Who Can Participate

Age: 12Years - 20Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient between 12 and 20 years old
  • Adolescent scoliosis requiring surgery based on radiological criteria (Cobb angle > 25° for thoracolumbar and lumbar scoliosis, > 35° for thoracic scoliosis, > 40° for double major scoliosis)
  • Patient affiliated with or beneficiary of a social security scheme
  • Patient and legal representative informed and not opposing the research
Not Eligible

You will not qualify if you...

  • Patient older than 20 years
  • Non-surgical scoliosis
  • Refusal to participate by the child or parents

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Clinique du dos

Bruges, France, 33520

Actively Recruiting

Loading map...

Research Team

J

Jean-François Oudet

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here